Clinical Trials Logo

Clinical Trial Summary

The main objective is to study the effect of engineered nanoparticles SPIONs (superparamagnetic iron oxide) on hemostasis. Nanoparticles will be incubated in blood and platelet aggregation will be measured. In parallel, nanoparticles will also be incubated in blood and then plasma proteins adsorbed on them will be separated and analyzed. The proteins found on the nanoparticles will be linked to the platelet aggregation observed to help developing innovative protein functionalized nanoprobes for optimized nanomedicine.


Clinical Trial Description

n/a


Study Design


NCT number NCT05690542
Study type Observational
Source Centre Hospitalier Universitaire Dijon
Contact DE MAISTRE Emmanuel
Phone 380293257
Email emmanuel.demaistre@chu-dijon.fr
Status Not yet recruiting
Phase
Start date February 2023
Completion date January 2024